The global demand for Lubiprostone Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022-2028.
Lubiprostone is a medication used for the treatment of chronic constipation in adults. It is used in the treatment of chronic idiopathic constipation, constipation in women caused due to irritable bowel syndrome, and opioid-induced constipation. Lubiprostone offers stomach pain relief and helps in the management of softer and frequent bowel movement. Lubiprostone is a laxative that helps in the treatment of problems related to constipation. It comes in a capsule form and should be taken along with food and water twice a day as per the prescription.
Market Dyanamics
Changing eating habits, increased sedentary lifestyle, rising consumption of junk food, and lack of physical activity are the factors responsible for the increased gastrointestinal problems such as constipation. It results in an increased demand for lubiprostone to relieve constipation and stomach pain. The increased mental and emotional stress due to hectic work schedules and other reasons had increased usage of anti-depressive drugs that led to the high prevalence of constipation. This factor is also boosting the demand for the lubiprostone resulting in the significant growth of the market. The other factors that are fuelling the market include the increased prevalence of irritable bowel syndrome amongst the female population and the growing prevalence of opioid-induced constipation.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each segment in the global market of lubiprostone.
Market Segmentation
This section of the lubiprostone market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.
By Type
- 8 mcg Capsules
- 24 mcg Capsules
By Applications
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for Lubiprostone market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Lubiprostone Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the lubiprostone market include Takeda Pharmaceuticals. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.